Pulse.

a daily field guide to health research that matters

◆ Console

‹ back to Tue · 13 Oct 2026

Daily digest

Tue · 13 Oct 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

📅 PUBMED DAILY TRIAGE — 2026-10-13 Window: 2026-10-11T09:00:00Z → 2026-10-13T09:14:55Z (CRDT) Topics scanned: 10 | Articles reviewed: 111 | Candidates evaluated: 125 High priority: 2 | Standard: 32 | Low/archive: 0 | Unsolicited finds: 0 Run status: SUCCESS

🔴🟠 HIGH PRIORITY (score ≥8 or qualifying flag) — Best Finds by Topic

Hematologic malignancies

Hematologic malignancies: No high-priority finds today (best candidate scored 6/10).

CBC-based diagnostics and machine learning in hematology

CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10).

Early cancer detection

42863103 · Development and Validation of a Blood Test Informed Risk Prediction Model for Lung Cancer-The Copenhagen Lung Cancer Risk Model (CPH-Lung). · 6/10 · Conservative triage based on the PubMed abstract: observational/journal article with direct watchlist relevance; score reflects metadata and abstract-level evidence only. 42861359 · Analytical and clinical validation of the EdenDx methylation assay as a noninvasive supportive triage tool for early detection of endometrial cancer in cervical scraping specimens. · 6/10 · Conservative triage based on the PubMed abstract: diagnostic/validation study with direct watchlist relevance; score reflects metadata and abstract-level evidence only.

AI/ML in clinical diagnostics and imaging

AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 7/10).

Precision oncology and genomic medicine

Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 6/10).

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 7/10).

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: No high-priority finds today (best candidate scored 6/10).

Aging, longevity, and population health

Aging, longevity, and population health: No high-priority finds today (best candidate scored 7/10).

Rare diseases with high unmet need

Rare diseases with high unmet need: No high-priority finds today (best candidate scored 7/10).

🟢⚪ STANDARD (5-7) — Top by Topic

Hematologic malignancies

42863677 · Impact of Prophylactic Steroids on CAR T-cell Related Toxicity for Relapsed and Refractory Non-Hodgkin Lymphoma. · 6/10 · Treatment Innovation 42859877 · Accelerated Glofitamab as Urgent Bridging to CAR T-Cell Therapy in High-Risk Relapsed/Refractory Large B-Cell Lymphoma. · 6/10 · Treatment Innovation

CBC-based diagnostics and machine learning in hematology

No retained standard-priority articles today.

Early cancer detection

42861255 · Micro/Nanostructured Materials and Microfluidic Diagnostic Platforms Enable Multimodal Detection of Circulating Tumor Cells. · 6/10 · Diagnostics

AI/ML in clinical diagnostics and imaging

42863783 · Artificial intelligence-assisted detection of oral cancer and oral potentially malignant disorders on smartphone images: a systematic review and meta-analysis. · 7/10 · Diagnostics 42862808 · A machine learning model for in-hospital mortality prediction in patients with sepsis-related myocardial injury. · 6/10 · Diagnostics 42861170 · A collaborative hybrid network with aggregated attention for pulmonary nodule detection. · 6/10 · Diagnostics 42860999 · Opportunistic Cardiovascular Risk Assessment in the Eye Clinic: Validation of a Retinal Deep Learning-Based 10-Year Atherosclerotic Cardiovascular Disease Estimator. · 6/10 · Diagnostics 42860582 · Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data. · 6/10 · Public Health

Precision oncology and genomic medicine

42863532 · The epigenetic landscape of hepatocellular carcinoma: from molecular mechanisms to early detection biomarkers and precision therapy. · 6/10 · Genomics/Precision Medicine 42863530 · Molecular landscape of chondrosarcoma: From tumor biology to therapeutic vulnerabilities. · 6/10 · Genomics/Precision Medicine 42860325 · Prognostic biomarkers in non-muscle-invasive bladder cancer: biological basis and evidence. · 6/10 · Genomics/Precision Medicine 42860034 · Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease. · 6/10 · Diagnostics 42863460 · Hitting KRAS G12D without the gut punch: Can immunotherapy make it last? · 5/10 · Treatment Innovation

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

42863770 · Perioperative immune-based treatment for cisplatin-eligible muscle-invasive bladder cancer: a meta-analysis of randomized controlled trials. · 7/10 · Treatment Innovation 42862446 · Effects of tyrosine kinase inhibitors in treatment of non small cell lung cancer patients with brain metastases, real world experience. · 6/10 · Treatment Innovation 42862337 · Prognostic value of diabetes-related clinical indices in patients with non-small cell lung cancer and comorbid type 2 diabetes receiving immune checkpoint inhibitor therapy. · 6/10 · Treatment Innovation 42862283 · Comparative toxicity and efficacy of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: real-world retrospective cohort study. · 6/10 · Treatment Innovation 42862216 · Antibody-drug conjugates in lung cancer: clinical development, therapeutic advances, and emerging challenges. · 6/10 · Treatment Innovation

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

42863556 · Effectiveness and Safety of Target-Specific RNA-Based Lipid-Lowering Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. · 6/10 · Treatment Innovation 42862748 · Failure of P-Wave Duration as a Surrogate Marker for Left Atrial Enlargement in African Americans: Insights from the Jackson Heart Study. · 6/10 · Diagnostics 42861473 · Understanding the Mortality Trends in Patients With Ventricular Arrhythmias and Cardiomyopathy: A 25-Year Retrospective Analysis From 1999-2024. · 6/10 · Public Health 42861258 · Pharmacist involvement in overweight and obesity care: An equity-focused systematic review. · 6/10 · Public Health 42860990 · Comparative analysis of postoperative complications and 30-day readmissions after CABG in diabetic vs. non-diabetic patients: a nationwide readmissions database study. · 6/10 · Public Health

Aging, longevity, and population health

42861492 · Treatment adherence and mental health in people with cystic fibrosis and advanced lung disease treated with elexacaftor/tezacaftor/ivacaftor. · 7/10 · Genomics/Precision Medicine 42862762 · Symptom-Guided Blood Biomarker Testing for Alzheimer's Disease. · 6/10 · Diagnostics 42860781 · Biological age acceleration and cardiovascular-kidney-metabolic syndrome progression: evidence from UK Biobank and NHANES. · 6/10 · Public Health 42860582 · Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data. · 6/10 · Public Health

Rare diseases with high unmet need

42861689 · Statin Exposure and Survival Outcomes in Amyotrophic Lateral Sclerosis in an Asian Cohort. · 7/10 · Genomics/Precision Medicine 42861492 · Treatment adherence and mental health in people with cystic fibrosis and advanced lung disease treated with elexacaftor/tezacaftor/ivacaftor. · 7/10 · Genomics/Precision Medicine 42860485 · Interventricular septal thickness for cardiomyopathic phenotype enrichment in patients with established left ventricular hypertrophy. · 7/10 · Genomics/Precision Medicine 42861773 · Astrocyte SMN Restoration and Forskolin Treatment Improve SMA Synaptic Pathology. · 5/10 · Drug Development

💡 UNSOLICITED FINDS

No high-signal out-of-watchlist items retained.

📊 TODAY'S BREAKDOWN

🔧 RUN NOTES